USMLE Forum Archives - USMLE Step 3 - th.ca5
th.ca5
sudha2015 - 04-18-11 04:18
As predicted by ADJUVANT ONLINE, what is the following patient’s risk of dying from his resected NSCLC despite platinum-based chemotherapy? 46-year old male with average comorbidities with a T2N1, stage 2B lesion.
a. 22%
b. 56%
c. 94%
d. 35%
sudha2015 - 04-18-11 04:18
As predicted by ADJUVANT ONLINE, what is the following patient’s risk of dying from his resected NSCLC despite platinum-based chemotherapy? 46-year old male with average comorbidities with a T2N1, stage 2B lesion.
a. 22%
b. 56%
c. 94%
d. 35%
Page 1
Page 1